Feline infectious peritonitis (FIP)

Feline infectious peritonitis, commonly known as FIP, is a severe and historically fatal viral disease caused by a mutated form of feline coronavirus. This devastating condition develops when a common and usually harmless intestinal coronavirus undergoes genetic mutations within an individual cat, transforming it into a highly pathogenic form that can attack cells throughout the body. FIP primarily affects young cats, with the majority of cases occurring in cats under two years of age, though cats of any age can develop the disease. The condition is found worldwide and represents one of the most challenging diagnoses in feline medicine due to its variable presentation and historically poor prognosis.

The development of FIP involves a complex interplay between viral mutation and the cat's immune response. Most cats become infected with feline enteric coronavirus early in life, typically through exposure to infected feces in multi-cat environments, and either eliminate the virus or become chronic shedders without developing disease. In a small percentage of infected cats, the coronavirus mutates in ways that allow it to infect macrophages, specialized immune cells that normally help fight infections. This mutated virus then spreads throughout the body via these infected immune cells, triggering an intense inflammatory response that damages multiple organ systems.

The impact of FIP on affected cats is profound and affects virtually every aspect of their health and wellbeing. The disease manifests in two primary forms: the effusive or wet form characterized by fluid accumulation in body cavities, and the non-effusive or dry form characterized by granulomatous lesions in various organs. Both forms cause progressive deterioration, with cats experiencing fever, weight loss, lethargy, and specific symptoms related to the organs affected. Prior to the development of effective antiviral treatments, FIP was considered universally fatal, representing a heartbreaking diagnosis for cat owners and veterinarians alike.

The landscape of FIP treatment has transformed dramatically in recent years with the development of antiviral medications that can effectively treat this once-fatal disease. Drugs including GS-441524 and molnupiravir have demonstrated remarkable success in treating FIP when administered appropriately, offering hope where none existed before. Early detection and prompt initiation of treatment are critical for achieving the best outcomes. Veterinary care remains essential for accurate diagnosis, treatment planning, and monitoring throughout the extended treatment course required to achieve remission.

The primary cause of feline infectious peritonitis is the mutation of feline enteric coronavirus into a pathogenic form capable of infecting and replicating within macrophages. Feline enteric coronavirus is extremely common in cat populations, particularly in multi-cat environments, where it spreads through the fecal-oral route. Most cats infected with this coronavirus experience only mild, self-limiting intestinal symptoms or remain completely asymptomatic. The mutation that leads to FIP development occurs spontaneously within individual cats, transforming the relatively benign enteric coronavirus into the deadly FIP virus that can disseminate throughout the body.

Genetic and hereditary factors play significant roles in determining which cats develop FIP following coronavirus exposure. Research has demonstrated that certain genetic factors influence susceptibility to FIP development, explaining why some cats exposed to coronavirus develop FIP while the vast majority do not. Purebred cats, particularly certain breeds, appear to have elevated FIP risk, suggesting inherited susceptibility factors. The exact genes involved are still being studied, but immune function genes likely play important roles in determining whether an individual cat can effectively contain coronavirus infection or allow mutation and disease development.

Environmental and lifestyle factors significantly influence the risk of FIP development, with multi-cat environments representing the highest risk situations. Catteries, shelters, breeding facilities, and households with many cats have higher coronavirus circulation rates and correspondingly higher FIP incidence. Stress from overcrowding, rehoming, surgery, or concurrent illness appears to increase FIP risk, possibly by suppressing immune function and allowing viral mutation and spread. Young cats in high-stress environments face the greatest risk, as their immune systems are still developing and may be less capable of containing coronavirus mutations.

Risk factors for FIP development are numerous and include both intrinsic cat factors and environmental exposures. Age is a major risk factor, with most FIP cases occurring in cats between three months and two years of age, though older cats can also develop the disease. Recent stress events such as adoption, surgery, or introduction of new cats to the household may trigger FIP development in cats harboring coronavirus. Concurrent infections, particularly with feline leukemia virus or feline immunodeficiency virus, increase FIP susceptibility by compromising immune function.

The mechanism of FIP development involves viral mutation, immune cell infection, and subsequent inflammatory cascade throughout the body. When feline coronavirus mutates in ways that allow it to efficiently infect macrophages, these infected immune cells carry the virus through the bloodstream to various organs and tissues. The immune system's attempt to contain these infected cells leads to intense inflammation, with granuloma formation and tissue damage in the dry form, or with protein-rich fluid leakage into body cavities in the wet form. The blood vessel inflammation characteristic of FIP causes the multisystem disease manifestations that make this condition so devastating and difficult to treat.

Early warning signs of feline infectious peritonitis are often vague and nonspecific, making early detection challenging for cat owners and veterinarians. Initial symptoms may include persistent low-grade fever that does not respond to antibiotic treatment, mild lethargy, and gradual decrease in appetite. Some cats develop subtle changes in behavior, becoming less playful or interactive than usual. Weight loss may begin during this early phase, though it is often gradual and may not be immediately apparent. Because these early symptoms overlap with many common feline illnesses, FIP is rarely suspected during the initial stages unless the cat has known risk factors such as recent acquisition from a multi-cat environment.

Common symptoms of FIP vary depending on whether the cat develops the effusive or non-effusive form of the disease. In the wet form, the most characteristic symptom is progressive abdominal distension caused by accumulation of yellow, viscous fluid in the abdominal cavity, which may give the cat a pot-bellied appearance. Similar fluid may accumulate in the chest cavity, causing labored breathing and reluctance to lie down. In the dry form, symptoms depend on which organs develop granulomatous lesions and may include jaundice if the liver is affected, kidney-related symptoms if the kidneys are involved, or neurological signs if the brain or spinal cord is targeted.

Behavioral changes associated with FIP often reflect the systemic inflammation and general malaise caused by the disease. Affected cats typically become progressively more lethargic and spend increasing amounts of time resting or hiding. Appetite usually decreases, sometimes dramatically, leading to visible weight loss and muscle wasting over days to weeks. Cats with FIP may seek out warm spots more frequently due to their persistent fever, and they often become less interested in grooming, leading to an unkempt appearance. Social cats may become withdrawn, while some cats become more clingy and seek increased attention from their owners.

Physical signs of FIP become more obvious as the disease progresses and can help differentiate FIP from other conditions. Abdominal distension in wet FIP creates visible and palpable swelling that can become quite pronounced. Jaundice, seen as yellowing of the whites of the eyes, gums, and skin, indicates liver involvement and is common in both forms of FIP. Ocular signs including uveitis, characterized by color changes in the iris, cloudiness, or visible debris in the eyes, occur frequently in dry FIP and should prompt immediate evaluation. Neurological signs in cats with central nervous system involvement may include head tilts, wobbly gait, seizures, or behavioral changes.

Symptom progression in FIP is typically relentless without treatment, with cats deteriorating over days to weeks depending on the form and severity of disease. Wet FIP often progresses more rapidly, with cats declining noticeably over one to three weeks as fluid accumulation increases. Dry FIP may progress more slowly over weeks to months, with gradual worsening of symptoms related to affected organs. Some cats develop mixed presentations with features of both wet and dry forms. Without antiviral treatment, the disease invariably progresses to terminal stages where quality of life becomes severely compromised.

Emergency symptoms requiring immediate veterinary attention in cats suspected of having FIP include severe difficulty breathing, which may indicate significant fluid accumulation in the chest cavity compromising lung function. Sudden collapse, complete refusal to eat or drink, or extreme weakness warrant emergency evaluation. Neurological emergencies including seizures, sudden inability to walk, or severe disorientation require immediate care. Any cat with suspected or confirmed FIP showing rapid deterioration should receive emergency veterinary assessment to determine if emergency fluid drainage or other interventions are needed while antiviral treatment is initiated.

Initial examination of a cat suspected of having FIP involves comprehensive physical assessment combined with detailed history regarding the cat's background and symptom development. Veterinarians will inquire about the cat's age, acquisition source, exposure to multi-cat environments, recent stressors, and timeline of symptom onset. Physical examination focuses on identifying hallmark signs including fever, abdominal distension or fluid waves indicating effusion, enlarged lymph nodes, jaundice, and ocular abnormalities. The presence of characteristic findings in a young cat with appropriate history raises strong suspicion for FIP and guides subsequent diagnostic testing.

Diagnostic tests for FIP have historically been challenging because no single test definitively confirms the diagnosis in all cases. Blood work typically reveals elevated globulin proteins with decreased albumin, creating a low albumin-to-globulin ratio characteristic of FIP. Complete blood count may show anemia and changes in white blood cell counts. If effusion is present, fluid analysis is extremely valuable, with FIP effusions showing high protein content, low cell counts, and characteristic straw-yellow color and viscosity. PCR testing of effusion fluid or tissue samples can detect feline coronavirus genetic material, though positive results require careful interpretation.

Differential diagnosis for FIP depends on the presentation and must rule out other causes of similar clinical signs. Cats with abdominal effusion require evaluation for other causes including heart disease, liver disease, and cancer. Cats with jaundice need assessment for hepatic lipidosis, cholangitis, and other liver conditions. Neurological signs may be caused by various infectious, inflammatory, or neoplastic conditions. Ocular inflammation has multiple potential causes including toxoplasmosis and other infections. Accurate diagnosis is essential because FIP treatment is expensive, prolonged, and should not be initiated without reasonable diagnostic certainty.

Diagnosis confirmation for FIP increasingly relies on immunohistochemistry or PCR testing of affected tissue samples, though effusion analysis combined with clinical findings often provides sufficient diagnostic confidence to initiate treatment. Testing for feline coronavirus antibodies is widely available but not diagnostic for FIP, as most cats in multi-cat environments have positive titers. The Rivalta test on effusion fluid provides supportive evidence when positive. Many veterinarians now initiate treatment based on a combination of consistent clinical signs, supportive laboratory findings, and characteristic effusion analysis, with diagnosis confirmed by response to antiviral therapy.

Emergency and immediate treatment for cats with FIP focuses on stabilization while definitive antiviral therapy is organized. Cats with significant respiratory distress due to chest effusions may require emergency therapeutic drainage to improve breathing. Severely dehydrated or anorexic cats benefit from intravenous fluid therapy and nutritional support. Anti-inflammatory medications, particularly corticosteroids, have historically been used for palliative care, though their role alongside antiviral therapy requires careful consideration. The priority in emergency FIP cases is stabilization sufficient to allow initiation of antiviral treatment, which represents the only intervention capable of addressing the underlying disease.

Medical management of FIP has been revolutionized by the development of effective antiviral medications, particularly nucleoside analog drugs that inhibit viral replication. GS-441524, originally developed for human coronavirus treatment, has demonstrated remarkable efficacy against FIP when administered daily for a minimum of 84 days. Molnupiravir, another antiviral agent, has also shown effectiveness and is increasingly available. These medications are typically administered orally, though injectable formulations exist for cats unable to take oral medication. Treatment duration is critical, as premature discontinuation frequently results in relapse, and most protocols require 12 weeks of daily medication.

Surgical options for FIP are limited and generally focus on managing complications rather than treating the underlying disease. Therapeutic drainage of effusions may provide temporary relief when fluid accumulation compromises breathing or causes significant discomfort. Surgical biopsies may be obtained to confirm diagnosis through immunohistochemistry in ambiguous cases. No surgical intervention addresses the viral infection itself, making antiviral therapy the essential component of any treatment plan. Surgical drainage is viewed as supportive care that may be necessary while antiviral medications take effect.

Supportive care during FIP treatment includes ensuring adequate nutrition, hydration, and management of concurrent symptoms. Appetite stimulants may be necessary for cats with decreased food intake, and some cats require assisted feeding during the initial treatment period. Pain management addresses discomfort associated with inflammation and effusions. Anti-nausea medications help cats tolerate oral antiviral administration. Keeping cats comfortable, warm, and stress-free supports their recovery and immune function during the treatment period.

Alternative and complementary treatments for FIP are limited, as antiviral therapy represents the only proven effective intervention. Prior to antiviral availability, various supportive and immunomodulatory treatments were attempted with limited success. Some practitioners incorporate immune-supporting supplements alongside antiviral therapy, though evidence for additional benefit is lacking. The focus of treatment should remain on proven antiviral medications administered according to established protocols, with complementary approaches considered only as adjuncts that do not interfere with primary treatment.

Treatment decision factors for FIP include diagnostic certainty, disease severity, form of disease, and practical considerations including medication accessibility and cost. Antiviral treatment requires significant financial investment and daily medication administration for 12 weeks or longer. Cats with neurological or ocular involvement may require extended treatment courses and have somewhat lower success rates than cats with effusive disease alone. Despite these challenges, treatment success rates exceeding 80-90 percent in appropriate candidates have transformed FIP from a uniformly fatal disease to a treatable condition, making treatment a reasonable choice for most affected cats.

Recovery timeline for cats undergoing FIP treatment follows a general pattern, though individual responses vary considerably. Many cats show initial improvement within the first one to two weeks of antiviral treatment, with reduction in fever, improved appetite, and increased energy levels. Effusions typically begin resolving within the first few weeks, though complete absorption may take longer. Blood work abnormalities gradually normalize over the treatment course, with globulin levels decreasing and albumin levels increasing toward normal values. The 84-day minimum treatment duration reflects the time needed to suppress viral replication sufficiently to prevent relapse, though some cats require extended treatment.

Post-treatment care for cats recovering from FIP involves careful monitoring for signs of relapse during the critical period following treatment completion. Veterinary rechecks with blood work are typically recommended at regular intervals during and after treatment, often monthly during treatment and then at 30 days, 60 days, and 90 days post-treatment. Owners should monitor for any return of previous symptoms including fever, decreased appetite, weight loss, or other signs that prompted the initial diagnosis. Maintaining a stress-free environment during recovery supports immune function and reduces relapse risk.

Prognosis factors for FIP recovery depend on several variables that influence treatment success rates. Cats with wet FIP generally have excellent response rates exceeding 90 percent when treated with appropriate antiviral protocols. Cats with neurological involvement have somewhat lower success rates, estimated at 60-70 percent, and may require longer treatment courses. Early treatment initiation before severe deterioration improves outcomes, while cats treated late in disease progression face more guarded prognoses. The specific antiviral medication, dosing protocol, and treatment duration all influence ultimate success.

Long-term outlook for cats that successfully complete FIP treatment is generally excellent, with most cats returning to normal health and life expectancy. Relapse rates following properly completed treatment courses are relatively low, estimated at 10-15 percent depending on study and disease form. Cats that relapse typically do so within three months of treatment completion and generally respond to retreatment. Cats that remain relapse-free for several months after treatment completion are considered cured and can be expected to live normal lives. Long-term monitoring through regular veterinary care helps catch any late relapses quickly.

Primary prevention of feline infectious peritonitis is challenging because the underlying feline enteric coronavirus is extremely common in cat populations and spreads easily in multi-cat environments. Reducing stress in young cats may help prevent the viral mutations that lead to FIP development, though this is difficult to prove definitively. Minimizing cat numbers in group housing situations reduces coronavirus transmission pressure and may lower FIP incidence. Maintaining excellent litter box hygiene, including frequent cleaning and adequate box numbers, reduces fecal-oral coronavirus transmission. Early weaning and isolation of kittens from known coronavirus-shedding adults has been attempted in breeding programs with variable success.

Environmental prevention measures focus on reducing coronavirus circulation and transmission in multi-cat settings. Ideally, cats should be housed in stable groups of three or fewer to minimize coronavirus transmission dynamics. New cats should be quarantined before introduction to established groups, and cats from high-risk environments like shelters should be recognized as potentially carrying coronavirus. Excellent ventilation, regular disinfection, and avoidance of overcrowding all contribute to reduced viral transmission. However, because coronavirus is so prevalent, complete prevention of exposure is rarely achievable in multi-cat situations.

Dietary considerations for FIP prevention are indirect and focus on supporting overall immune health rather than preventing coronavirus infection specifically. Feeding high-quality, nutritionally complete diets supports optimal immune function, which may help cats resist viral mutation and disease development. Maintaining healthy body condition through appropriate feeding reduces physiological stress. No specific dietary interventions have been proven to prevent FIP development in coronavirus-exposed cats, though general nutritional health remains important for overall disease resistance.

Health maintenance practices that may reduce FIP risk include keeping cats generally healthy through regular veterinary care, appropriate vaccination, and parasite prevention. Reducing stress through environmental enrichment, stable social groups, and predictable routines supports immune function. An FIP vaccine was previously available but showed limited efficacy and is no longer widely used or recommended. Managing concurrent diseases that could suppress immune function may reduce the likelihood of FIP development in coronavirus-infected cats.

Early intervention in FIP involves prompt recognition of suspicious symptoms and rapid diagnostic workup rather than preventing initial infection. Cat owners should be aware of FIP symptoms, particularly in young cats acquired from multi-cat environments. Veterinary evaluation should be sought promptly when persistent fever, weight loss, abdominal distension, or other concerning signs develop. Early diagnosis allows earlier treatment initiation, which is associated with better outcomes. The availability of effective treatment makes early intervention more valuable than ever, as prompt diagnosis can lead to successful treatment and recovery.

Daily management of a cat undergoing FIP treatment requires commitment to daily medication administration and careful monitoring of the cat's condition. Antiviral medications must be given according to prescribed schedules, typically once daily, at the same time each day for optimal blood levels. Owners should track their cat's appetite, activity level, weight, and any symptoms daily, noting improvements or concerns for veterinary discussion. Maintaining consistent feeding schedules with high-quality, palatable food encourages adequate nutrition during recovery. Minimizing stress through routine, quiet environment, and gentle handling supports the healing process.

Home environment considerations for cats with FIP focus on comfort and stress reduction during the treatment period. A quiet, warm space away from household activity provides a recovery sanctuary for affected cats. Easy access to food, water, and litter box without requiring climbing or jumping accommodates cats with decreased energy. Comfortable bedding in a clean, draft-free area supports rest and recovery. Multi-cat households may need to separate the affected cat temporarily if interactions with other cats cause stress, though FIP itself poses minimal transmission risk to housemates.

Quality of life assessment during FIP treatment helps guide decisions about treatment continuation and adjustment. Cats responding to treatment should show progressive improvement in energy, appetite, and general demeanor over the first few weeks. Pain or discomfort should be managed appropriately, and any decline in quality of life should prompt veterinary consultation. Many cats maintain good quality of life throughout treatment once initial symptoms begin resolving. The goal is a comfortable cat that is eating, drinking, and showing interest in normal activities while medication works to eliminate the virus.

Monitoring and ongoing care during FIP treatment involves regular veterinary rechecks to assess response and adjust treatment as needed. Blood work monitoring tracks protein levels and other parameters that indicate treatment response. Weight monitoring confirms adequate nutrition and helps assess overall progress. Any new or worsening symptoms require prompt veterinary evaluation to determine if they represent treatment failure, drug side effects, or unrelated issues. Consistent communication with the treating veterinarian ensures optimal care throughout the extended treatment course.

Caregiver support is particularly important for owners of cats with FIP, as the diagnosis carries significant emotional and financial weight. The treatment course is long and requires substantial commitment, and owners benefit from understanding the expected timeline and typical response patterns. Online support communities of FIP cat owners provide emotional support and practical advice from others who have navigated treatment. Financial planning for the medication costs, veterinary visits, and potential extended treatment helps reduce stress. Many owners find that witnessing their cat's improvement during treatment is deeply rewarding after the initial fear and uncertainty of diagnosis.

High-risk breeds for feline infectious peritonitis include several purebred cat breeds that appear to have genetic susceptibility factors. Abyssinians, Bengals, Birmans, British Shorthairs, Burmese, Himalayans, Persians, Ragdolls, and Rex breeds have been reported to have elevated FIP incidence in various studies. The reasons for increased purebred susceptibility likely relate to immune function genes and potentially to the multi-cat breeding environments where these cats originate. However, FIP can and does occur in cats of all breeds and mixed-breed cats, and lifestyle factors often outweigh breed considerations in determining individual risk.

Moderate-risk categories for FIP include any young cats recently acquired from multi-cat environments, regardless of breed. Cats from shelters, rescues, catteries, and pet stores face elevated FIP risk due to coronavirus exposure in these high-density settings. Cats experiencing significant stressors such as rehoming, surgery, or concurrent illness may have increased risk of FIP development if carrying coronavirus. Mixed-breed cats are generally at lower risk than purebreds statistically, though their risk increases substantially if they originate from high-density housing situations.

Screening recommendations for FIP differ from many genetic conditions because no pre-symptomatic test can identify cats that will develop FIP. Coronavirus antibody testing detects exposure but does not predict which exposed cats will develop FIP, as most exposed cats never develop disease. Breeders can attempt to reduce coronavirus circulation through management practices, though eliminating the virus from catteries is extremely difficult. Prospective cat owners should be aware that cats from multi-cat environments carry higher FIP risk, and should seek veterinary evaluation promptly if suspicious symptoms develop in newly acquired cats.

Commonly co-occurring conditions with FIP reflect the multisystem inflammatory nature of the disease. Uveitis and other ocular inflammation occur in many cats with dry FIP and may be the initial presenting sign. Neurological disease including meningitis and encephalitis develops when the virus affects the central nervous system. Liver inflammation causes jaundice and elevated liver enzymes in affected cats. Kidney involvement may cause proteinuria and azotemia. Anemia, either from chronic inflammation or secondary immune-mediated destruction, commonly accompanies FIP. Managing these concurrent conditions alongside antiviral therapy improves overall outcomes.

Conditions with similar symptoms to FIP present diagnostic challenges and must be differentiated through appropriate testing. Feline leukemia virus and feline immunodeficiency virus can cause similar clinical decline and may co-exist with FIP. Bacterial infections, particularly pyothorax and bacterial peritonitis, can cause effusions that mimic FIP effusions. Lymphoma and other cancers may present with effusions, weight loss, and organ involvement similar to FIP. Heart disease causes chest and abdominal effusions that must be distinguished from FIP effusions. Accurate diagnosis is essential because treatment approaches differ dramatically between these conditions.

Potential complications of FIP, particularly in untreated or advanced cases, include progressive organ failure and secondary infections. Severe effusion accumulation can compromise breathing when fluid fills the chest cavity or cause abdominal discomfort when filling the abdomen. Neurological involvement may cause permanent deficits if treatment is delayed or ineffective. Ocular complications can result in permanent vision impairment. Secondary bacterial infections may develop in severely immunocompromised cats. Early treatment with effective antiviral medication minimizes complication risk and preserves organ function.